The UQ- IITD Academy of Research (UQIDAR) is a joint venture with the key focus on a transnational joint PhD program. UQIDAR aims to attract the best global talent including elite students, academics, researchers and scientists to work on goal directed, cross-disciplinary grand challenges that are of interest to Australia, India and the global community and that also align with UQ and IITD research strengths. The expectation is that, over time, prominent research institutes in and around New Delhi would be invited to join UQIDAR as Associate Partners in order to expand the research into a broad-based, multi-disciplinary collaboration spanning Medicine, Biology, Biotechnology, Agriculture, STEM, Humanities, and Economics disciplines.

The collaboration will also enable the establishment of a mobility or fellowship scheme to enable academics and postdoctoral fellows to spend time at each institute, expanding and deepening research collaborations and offering career development opportunities for early career researchers.

The Academy will yield significant benefits to both UQ and IITD including:

  • Enhanced research links, enriching the research endeavour of both institutions and enabling interdisciplinary research that tackles global issues at grander scale;
  • Opportunities to access international research and industry funding;
  • Increase industry engagement to support international internships and placements for students at both institutions;
  • Increase the number of PhD graduates and contribution to national research outputs;
  • Increase enrolments from the best and brightest students through attractive program offerings and expanded mobility opportunities;
  • Provide opportunities for UQ and IITD to attract elite students from countries such as Bangladesh, Sri Lanka and Nepal into the program; and
  • Heightened profile for both institutions nationally as well as globally.

The UQIDAR collaboration will also involve strong industry linkages whereby from year two, industry will partner to support PhD students and projects. At a steady state, it is expected that one third of the joint PhD students will be supported by industry funding and through direct industry engagement determined by their research projects. Industry engagement is expected to be mainly from (but not limited to) Australian and Indian Industry.

About the Joint PhD program

UQIDAR will enable students to enrol in a joint PhD with supervision from both institutions. Upon successful completion of the program, students will be jointly awarded a PhD degree from both UQ and IITD. The UQIDAR will allow for scale and sustainability. Current modelling aims for a steady state of approximately 300 PhD candidates by the tenth year of operation. Furthermore, by the end of the tenth year, it is expected that the Academy will have graduated more than 360 candidates. These alumni will be across a broad range of disciplines and will, we expect, be well-placed in industry R&D labs and in academic institutions.

View the UQIDAR advisor handbook

Timeline - deadline for projects is 9 August

Round 2, 2019*

Date

Item

5 July

Call for projects opens

9 August

Call for projects close

28 August

Academy Management Committee (AMC) approve projects for advertisement

9 September

Applications open

4 October

Applications close

25 October – 8 November

Supervisors shorlist applicants

15 November

Academy Joint Admissions Sub-committee (AJAS) shortlists applicants for interview

29 November – 30 November

Interviews

2-3 December

Academy Program Advisory Committee (APAC) reviews shortlisted applicants

13 December

Offers sent to students

20 December

Deadline to accept offers

28 December

Cohort commences at IITD

*Dates are subject to change

Submit a project

UQIDAR calls for research projects in February and July each year.  Submit your project proposal online by 9 August, 2019 to promote your project in September 2019 for students commencing in late December 2019/January 2020.

Submit a project

More information

Please visit the UQ- IITD Academy of Research website for further information.